Robert Michael Floyd - Net Worth and Insider Trading
Robert Michael Floyd Net Worth
The estimated net worth of Robert Michael Floyd is at least $12,527 dollars as of 2024-05-22. Robert Michael Floyd is the COO of Processa Pharmaceuticals Inc and owns about 6,593 shares of Processa Pharmaceuticals Inc (PCSA) stock worth over $12,527. Details can be seen in Robert Michael Floyd's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Robert Michael Floyd has not made any transactions after 2021-06-22 and currently still holds the listed stock(s).
Transaction Summary of Robert Michael Floyd
Robert Michael Floyd Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert Michael Floyd owns 1 companies in total, including Processa Pharmaceuticals Inc (PCSA) .
Click here to see the complete history of Robert Michael Floyd’s form 4 insider trades.
Insider Ownership Summary of Robert Michael Floyd
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PCSA | Processa Pharmaceuticals Inc | 2021-06-22 | Chief Operating Officer |
Robert Michael Floyd Latest Holdings Summary
Robert Michael Floyd currently owns a total of 1 stock. Robert Michael Floyd owns 6,593 shares of Processa Pharmaceuticals Inc (PCSA) as of June 22, 2021, with a value of $12,527.
Latest Holdings of Robert Michael Floyd
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PCSA | Processa Pharmaceuticals Inc | 2021-06-22 | 6,593 | 1.90 | 12,527 |
Holding Weightings of Robert Michael Floyd
Robert Michael Floyd Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert Michael Floyd has made a total of 1 transactions in Processa Pharmaceuticals Inc (PCSA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Processa Pharmaceuticals Inc is the acquisition of 100 shares on June 22, 2021, which cost Robert Michael Floyd around $14,060.
Insider Trading History of Robert Michael Floyd
- 1
Robert Michael Floyd Trading Performance
GuruFocus tracks the stock performance after each of Robert Michael Floyd's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert Michael Floyd is 3.74%. GuruFocus also compares Robert Michael Floyd's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert Michael Floyd within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Robert Michael Floyd's insider trading performs compared to the benchmark.
Performance of Robert Michael Floyd
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -4.43 | | | | | |
| Relative Return to S&P 500(%) | -7.28 | | | | | |
Robert Michael Floyd Ownership Network
Robert Michael Floyd Owned Company Details
What does Processa Pharmaceuticals Inc do?
Who are the key executives at Processa Pharmaceuticals Inc?
Robert Michael Floyd is the Chief Operating Officer of Processa Pharmaceuticals Inc. Other key executives at Processa Pharmaceuticals Inc include director & 10 percent owner & President & CEO David Young , Chief Business - Strategy Off Patrick Lin , and Chief Executive Officer George K Ng .
Processa Pharmaceuticals Inc (PCSA) Insider Trades Summary
Over the past 18 months, Robert Michael Floyd made no insider transaction in Processa Pharmaceuticals Inc (PCSA). Other recent insider transactions involving Processa Pharmaceuticals Inc (PCSA) include a net purchase of 161,000 shares made by David Young , a net purchase of 10,000 shares made by George K Ng , and a net purchase of 8,000 shares made by Justin W Yorke .
In summary, during the past 3 months, insiders sold 0 shares of Processa Pharmaceuticals Inc (PCSA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Processa Pharmaceuticals Inc (PCSA) were sold and 69,000 shares were bought by its insiders, resulting in a net purchase of 69,000 shares.
Processa Pharmaceuticals Inc (PCSA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Processa Pharmaceuticals Inc Insider Transactions
Robert Michael Floyd Mailing Address
Above is the net worth, insider trading, and ownership report for Robert Michael Floyd. You might contact Robert Michael Floyd via mailing address: C/o Processa Pharmaceuticals, Inc., 7300 Coca Cola Drive, Suite 106, Hanover Md 21076.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
